BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37184233)

  • 21. Allosteric Molecular Switches in Metabotropic Glutamate Receptors.
    Orgován Z; Ferenczy GG; Keserű GM
    ChemMedChem; 2021 Jan; 16(1):81-93. PubMed ID: 32686363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asymmetric functioning of dimeric metabotropic glutamate receptors disclosed by positive allosteric modulators.
    Goudet C; Kniazeff J; Hlavackova V; Malhaire F; Maurel D; Acher F; Blahos J; Prézeau L; Pin JP
    J Biol Chem; 2005 Jul; 280(26):24380-5. PubMed ID: 15863499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications.
    Yin S; Niswender CM
    Cell Signal; 2014 Oct; 26(10):2284-97. PubMed ID: 24793301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asymmetric activation of class C GPCRs.
    Liu H; Li Y; Gao Y
    Prog Mol Biol Transl Sci; 2023; 195():77-87. PubMed ID: 36707156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical potential of GABAB receptor modulators.
    Ong J; Kerr DI
    CNS Drug Rev; 2005; 11(3):317-34. PubMed ID: 16389296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional selectivity induced by mGlu₄ receptor positive allosteric modulation and concomitant activation of Gq coupled receptors.
    Yin S; Zamorano R; Conn PJ; Niswender CM
    Neuropharmacology; 2013 Mar; 66():122-32. PubMed ID: 22426233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structures of G
    Lin S; Han S; Cai X; Tan Q; Zhou K; Wang D; Wang X; Du J; Yi C; Chu X; Dai A; Zhou Y; Chen Y; Zhou Y; Liu H; Liu J; Yang D; Wang MW; Zhao Q; Wu B
    Nature; 2021 Jun; 594(7864):583-588. PubMed ID: 34135510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential.
    Gregory KJ; Dong EN; Meiler J; Conn PJ
    Neuropharmacology; 2011 Jan; 60(1):66-81. PubMed ID: 20637216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of allosteric modulators of GPCRs for treatment of CNS disorders.
    Nickols HH; Conn PJ
    Neurobiol Dis; 2014 Jan; 61():55-71. PubMed ID: 24076101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allosteric Binding Site and Activation Mechanism of Class C G-Protein Coupled Receptors: Metabotropic Glutamate Receptor Family.
    Feng Z; Ma S; Hu G; Xie XQ
    AAPS J; 2015 May; 17(3):737-53. PubMed ID: 25762450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The metabotropic glutamate receptors: structure, activation mechanism and pharmacology.
    Pin JP; Acher F
    Curr Drug Targets CNS Neurol Disord; 2002 Jun; 1(3):297-317. PubMed ID: 12769621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In silico approaches towards the understanding of the structure-function relationships in metabotropic glutamate receptors (mGluRs) and other family C GPRCs.
    Costantino G
    Curr Pharm Des; 2006; 12(17):2159-73. PubMed ID: 16796561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The computational modeling of allosteric modulation of metabotropic glutamate receptors.
    Pérez-Benito L; Llinas Del Torrent C; Pardo L; Tresadern G
    Adv Pharmacol; 2020; 88():1-33. PubMed ID: 32416864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterodimers revolutionize the field of metabotropic glutamate receptors.
    Belkacemi K; Rondard P; Pin JP; Prézeau L
    Neuroscience; 2024 Jun; ():. PubMed ID: 38936459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurobiological Insights from mGlu Receptor Allosteric Modulation.
    O'Brien DE; Conn PJ
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26647381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structures of human mGlu2 and mGlu7 homo- and heterodimers.
    Du J; Wang D; Fan H; Xu C; Tai L; Lin S; Han S; Tan Q; Wang X; Xu T; Zhang H; Chu X; Yi C; Liu P; Wang X; Zhou Y; Pin JP; Rondard P; Liu H; Liu J; Sun F; Wu B; Zhao Q
    Nature; 2021 Jun; 594(7864):589-593. PubMed ID: 34135509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural determinants of allosteric antagonism at metabotropic glutamate receptor 2: mechanistic studies with new potent negative allosteric modulators.
    Lundström L; Bissantz C; Beck J; Wettstein JG; Woltering TJ; Wichmann J; Gatti S
    Br J Pharmacol; 2011 Sep; 164(2b):521-37. PubMed ID: 21470207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.
    Maksymetz J; Moran SP; Conn PJ
    Mol Brain; 2017 Apr; 10(1):15. PubMed ID: 28446243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of a dimeric metabotropic glutamate receptor by intersubunit rearrangement.
    Brock C; Oueslati N; Soler S; Boudier L; Rondard P; Pin JP
    J Biol Chem; 2007 Nov; 282(45):33000-8. PubMed ID: 17855348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural and Biophysical Mechanisms of Class C G Protein-Coupled Receptor Function.
    Ellaithy A; Gonzalez-Maeso J; Logothetis DA; Levitz J
    Trends Biochem Sci; 2020 Dec; 45(12):1049-1064. PubMed ID: 32861513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.